Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02623361 · ClinicalTrials.gov registry record · Phase 4
A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT02623361 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 80 participants.
The verdict
NCT02623361, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
Patients undergoing arthroscopic hip surgery have been shown to have significant post-operative pain that may delay discharge, recovery, and early mobilisation. A pre-operative regional anesthesia technique, the fascia iliaca block may be an effective method for acute post-operative analgesia. This is a prospective, randomized controlled study of the preoperative fascia iliaca block for patients undergoing hip arthroscopy. The enrolled patients will be randomized to receive either a fascia iliaca block with the local anesthetic ropivacaine or to have a sham block. All patients will receive a general anesthetic for the hip arthroscopy.
Interventions
- DRUG Peripheral Nerve Block
- DRUG Sham Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02623361
The ClinicalTrials.gov registry entry for NCT02623361 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peripheral Nerve Block is the first listed.
NCT02623361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02623361 about?
NCT02623361 is a clinical study titled "A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy". Patients undergoing arthroscopic hip surgery have been shown to have significant post-operative pain that may delay discharge, recovery, and early mobilisation. A pre-operative regional anesthesia technique, the fascia iliaca block may be an effective method for acute post-operative analgesia. This...
What is the current status of trial NCT02623361?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2015-02. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02623361?
The interventions under investigation include: Peripheral Nerve Block (DRUG), Sham Block (DRUG).
Who is sponsoring clinical trial NCT02623361?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.